Prologue co-founder and CEO Lovisa Afzelius shares how Prologue is harnessing the viral proteome and viral evolution to discover and develop powerful new therapeutics. More from Flagship @ JPM2025 here.
Related Companies
- Prologue Medicines Founded: 2021
